Hypertension guidelines What’s all the controversy about 2015

Slides:



Advertisements
Similar presentations
JNC 8 Guidelines….
Advertisements

Etiology Primary hypertension 95% of all cases Secondary hypertension – 5% of all cases – Chronic renal disease – most common White coat hypertension –
CVD prevention & management: a new approach for primary care Rod Jackson School of Population Health University of Auckland New Zealand.
Hypertension Guidelines 2014
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.
Type 2 diabetes and high blood pressure How explosive is the cocktail?
Epidemiology Prevalence Increase with age 25% of the white males vs. 17% in white females 44% of black males vs. 37% in black femals Indifference between.
Hypertension: JNC 7 Guidelines Steven W Harris MHS PA-C.
William B. Kannel, MD, FACC Former Director, Framingham Heart Study
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT study overview Double-blind, randomized trial to determine whether.
DR. IDOWU AKOLADE EDM DIVISION LUTH
Casablanca, le 30 Avril 2011 MEDITERANEAN GROUP FOR STUDY DIABETES.
Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal
 Update on Hypertension Troy L. Randle, DO, FACC, FACOI.
10/5/2015. Hypertension GuidelinesDate JNC JNC JNC NICE Guidelines 2011 ESC / ESH Hypertension Guidelines ESC Guideline2007.
Peter Emery, MD Specialist in Clinical Hypertension InterMed Portland, ME.
DION GALLANT, MD PRIMARY CARE SERVICE LINE MEDICAL DIRECTOR PRESBYTERIAN MEDICAL GROUP JNC 8.
Combination Therapy for Hypertension Summary and Comment by Harlan M. Krumholz, MD, SM Published in Journal Watch Cardiology December 3, 2008Journal Watch.
1 Current & New treatment strategies to address CV Risk.
-Greatest Achievements in Endocrinology – Jose Mario F. de Oliveira, MD, Ph.D. -Brigham&Womens Hospital – Endocrinology, Hypertension&Diabetes Division.
The Renin-Angiotensin- Aldosterone System: Linking New Data and Mechanisms for Cardiovascular Risk Reduction VBWG.
2007 Hypertension as a Public Health Risk January, 2007.
Treatment of Hypertension in Adults With Diabetes DR AMAL HARFOUSH.
Journal Club February 7, 2014 Sadie T. Velásquez, MD.
Date of download: 6/25/2016 From: Blood Pressure and Mortality in U.S. Veterans With Chronic Kidney Disease: A Cohort Study Ann Intern Med. 2013;159(4):
Date of download: 7/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Decline in Estimated Glomerular Filtration Rate and.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Making Sense of Statistics in Clinical Trial Reports:
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/AHA 2011 Expert Consensus Document on Hypertension.
Antonio Coca, MD, PhD, FRCP, FESC
Management of Hypertension according to JNC 7
Dr John Cox Diabetes in Primary Care Conference Cork
Clinical Management of primary hypertension
An analysis of 22,672 patients from the CLARIFY registry
Hypertension In The Stroke Patient
David Antecol, M.D., FACC, FASH, FRCP(C) Specialist in Clinical Hypertension (American Society of Hypertension) Disclosures: None.
Redefining Quality Care in T2DM Patients with CV Disease
The SPRINT Research Group
Hypertension in the Post SPRINT era
JNC VIII Hypertension.
Hypertension JNC VIII Guidelines.
Copyright © 2015 American Medical Association. All rights reserved.
Hypertension Guidelines-JNC 8
Blood Pressure and Age in Controlling Hypertension
Copyright © 2011 American Medical Association. All rights reserved.
Hypertension.
Copyright © 2017 American Academy of Pediatrics.
Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.
Cholesterol practice questions
Copyright © 2007 American Medical Association. All rights reserved.
Hypertensive Guidelines
Achieving the Clinical Potential of RAAS Blockade
Teaching Tool: Blood Pressure Classification
Hypertension: A Risk Factor For Stroke
Systolic Blood Pressure Intervention Trial (SPRINT)
Progress and Promise in RAAS Blockade
A. Heart failure: A challenge to the healthcare delivery system
Step Care Therapy for Hypertension in Diabetic Patients
Insights from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Lowering of SBP by 20 mm Hg Reduces Cardiovascular Risk by Half
Table of Contents Why Do We Treat Hypertension? Recommendation 5
Beth Wallace, BSN, RN-BC, FNP-S Fairfield University Summer 2010
Primary Hypertension Max C. Reif, M.D.
Managing Blood Pressure
Pharmacological Treatment of Hypertension Update 2012
JNC Evidence-Based Guideline for the Management of
Measuring Blood Pressure
Volume 75, Issue 1, Pages (January 2009)
JNC Evidence-Based Guideline for the Management of
Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.
Stroke Prevention: An Evidence-Based Update
Presentation transcript:

Hypertension guidelines What’s all the controversy about 2015 Kevin M Hayes D.O. FACC

Disclosures Nothing to disclose

Hypertension guidelines Thanks for clearing that up for me – NOT Really

Objectives Brief review of pathophysiology Scope of the problem JNC – 8 ACC / AHA “End of the day”

HTN leads to an increased risk of death from stroke and heart disease 8x Cardiovascular Mortality Risk 4x 2x Hypertension is a serious health issue Hypertension significantly increases ones risk of CV mortality For every 20mm Hg, one doubles their CV mortality risk CV mortality risk doubles for every 20 mmHg increase in systolic blood pressure.1,2 Systolic BP / Diastolic BP (mmHg) Chobanian et al. Hypertension 2003;42:1206-1252; 2Lancet 2002;360:1903-1913

Prevalence of risk factors – Western population ( Framingham) Hypertension – 20 % > 65 y.o. 65 % Smoking 31% Overweight 54% Hyperlipidemia 55%

Problem Magnitude Hypertension( HTN) is the most common primary diagnosis in America. 35 million office visits are as the primary diagnosis of HTN. 50 million or more Americans have high BP. Worldwide prevalence estimates for HTN may be as much as 1 billion. 7.1 million deaths per year may be attributable to hypertension.

Figure 10. Stroke mortality rate in each decade of age versus usual blood pressure at the start of that decade. Figure 10. Stroke mortality rate in each decade of age versus usual blood pressure at the start of that decade. Source: Reprinted with permission from Elsevier (The Lancet, 2002;360:1903–1913). Aram V. Chobanian et al. Hypertension. 2003;42:1206-1252 Copyright © American Heart Association, Inc. All rights reserved.

Types of Hypertension Secondary HTN: less common cause of HTN ( 5%). Primary HTN: also known as essential HTN. accounts for 95% cases of HTN. no universally established cause known. Secondary HTN: less common cause of HTN ( 5%). secondary to other potentially rectifiable causes.

Identifiable Causes of HTN Sleep apnea Drug-induced or related causes Chronic kidney disease Primary aldosteronism Renovascular disease Chronic steroid therapy and Cushing’s syndrome Pheochromocytoma Coarctation of the aorta Thyroid or parathyroid disease

Figure 16. Algorithm for treatment of hypertension. Aram V. Chobanian et al. Hypertension. 2003;42:1206-1252 Copyright © American Heart Association, Inc. All rights reserved.

JNC – 8 Expert writing group

In patients 60 years or over, start treatment in blood pressures >150 mm Hg systolic or >90 mm Hg diastolic and treat to under those thresholds. In patients <60 years, treatment initiation and goals should be 140/90 mm Hg, the same threshold used in patients >18 years with either chronic kidney disease (CKD) or diabetes. In nonblack patients with hypertension, initial treatment can be a thiazide-type diuretic, CCB, ACE inhibitor, or ARB, while in the general black population, initial therapy should be a thiazide-type diuretic or CCB. In patients >18 years with CKD, initial or add-on therapy should be an ACE inhibitor or ARB, regardless of race or diabetes status.

JNC 8 is mostly in line with the European Society of Hypertension (ESH) guidelines released earlier this year, which suggested a target of <140 mm Hg systolic BP for "all" patients, with some caveats In patients with diabetes, the ESH guidelines suggest a diastolic BP of <85 mm Hg, and for patients under 80 years, they suggest a target of between 140 and 150, going lower only if the patient is fit and in good health

Copyright © 2015 American Medical Association. All rights reserved. JAMA. 2014;311(5):507-520. doi:10.1001/jama.2013.284427 Date of download: 4/23/2015 Copyright © 2015 American Medical Association. All rights reserved.

Treatment of Hypertension in Patients With Coronary Artery Disease A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension Circulation – May 2015

We felt the best evidence [to prevent future cardiovascular events] was to reduce pressure below 140/90 mm Hg, but a goal pressure of less than 130/80 mm Hg may be appropriate in some cases; we left it to the discretion of physicians to decide which blood pressure target to choose,”

CAD PATIENTS - >80 Y.O. – LESS THAN 150/90 ACC/AHA 2015 CAD PATIENTS - >80 Y.O. – LESS THAN 150/90

Hypertension guidelines Now I’m really confused

Any ?